These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Purinergic control of apical plasma membrane PI(4,5)P2 levels sets ENaC activity in principal cells. Pochynyuk O; Bugaj V; Vandewalle A; Stockand JD Am J Physiol Renal Physiol; 2008 Jan; 294(1):F38-46. PubMed ID: 17913833 [TBL] [Abstract][Full Text] [Related]
3. Abnormal EGF-dependent regulation of sodium absorption in ARPKD collecting duct cells. Veizis IE; Cotton CU Am J Physiol Renal Physiol; 2005 Mar; 288(3):F474-82. PubMed ID: 15522985 [TBL] [Abstract][Full Text] [Related]
4. Hypotonicity stimulates renal epithelial sodium transport by activating JNK via receptor tyrosine kinases. Taruno A; Niisato N; Marunaka Y Am J Physiol Renal Physiol; 2007 Jul; 293(1):F128-38. PubMed ID: 17344192 [TBL] [Abstract][Full Text] [Related]
5. Functional polymorphisms in the alpha-subunit of the human epithelial Na+ channel increase activity. Tong Q; Menon AG; Stockand JD Am J Physiol Renal Physiol; 2006 Apr; 290(4):F821-7. PubMed ID: 16249274 [TBL] [Abstract][Full Text] [Related]
6. Evidence for epidermal growth factor receptor as negative-feedback control in aldosterone-induced Na+ reabsorption. Grossmann C; Freudinger R; Mildenberger S; Krug AW; Gekle M Am J Physiol Renal Physiol; 2004 Jun; 286(6):F1226-31. PubMed ID: 14749256 [TBL] [Abstract][Full Text] [Related]
7. Regulation of the epithelial Na+ channel (ENaC) by phosphatidylinositides. Pochynyuk O; Tong Q; Staruschenko A; Ma HP; Stockand JD Am J Physiol Renal Physiol; 2006 May; 290(5):F949-57. PubMed ID: 16601296 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor stimulates phospholipase cgamma1 in cultured rabbit corneal epithelial cells. Islam M; Akhtar RA Exp Eye Res; 2000 Mar; 70(3):261-9. PubMed ID: 10712812 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor regulates the transition from basal sodium absorption to anion secretion in cultured endometrial epithelial cells. Deachapunya C; O'Grady SM J Cell Physiol; 2001 Feb; 186(2):243-50. PubMed ID: 11169461 [TBL] [Abstract][Full Text] [Related]
10. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor. Shah BH; Olivares-Reyes JA; Catt KJ Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation. Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635 [TBL] [Abstract][Full Text] [Related]
12. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity. Gardner DP; Shimizu N J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561 [TBL] [Abstract][Full Text] [Related]
13. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin. Wang Z; Wang M; Carr BI J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308 [TBL] [Abstract][Full Text] [Related]